Assertio医疗 ASRT 深 沪
等待开盘 04-17 09:30:00 美东时间
18.02
0.000
0.00%
华盛通- 最 高18.06
- 今 开18.01
- 成交量 24.63万股
- 最 低 18.01
- 昨 收 18.02
- 总市值 1.16亿
- 52周最高 20.45
- 市盈率 静 --
- 换手率 3.82%
- 52周最低 8.61
- 委 比 75.50%
- 总股本 644.52万
- 历史最高 393.90
- 量 比 0.57
- 振 幅 0.28%
- 历史最低 7.7055
- 每 手 1
- 风险率 2.20%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Are AVNS, LEG, ASRT Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
04-14 22:58
美股大行评级 | 小摩上调Lumentum控股目标价从565美元升至950美元；大小摩齐上调美国铝业目标价
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从13美元升至13.5美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8.25美元升至9美元
04-10 18:27
Lake Street Downgrades Assertio Hldgs to Hold, Lowers Price Target to $18
Lake Street analyst Thomas Flaten downgrades Assertio Hldgs (NASDAQ:ASRT) from Buy to Hold and lowers the price target from $45 to $18.
04-09 23:30
Cosette Pharmaceuticals Acquires The U.S. Sales And Distribution Rights For A Portfolio Of 7 Branded Products From Assertio Holdings
-- Adds Portfolio of Branded Products with $48.9 million in 2025 Net Sales and an Established Commercial Presence ---- SYMPAZAN® Establishes a Neurology Rare Disease Footprint within Cosette ---- Additional Brands
04-09 04:15
Top 2 Health Care Stocks That May Implode In April
Health care stocks warning for momentum investors. RSI indicator used to predict short term performance. Alkermes & Assertio overbought.
04-01 20:34
电话会总结 ｜ Assertio(ASRT)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Assertio Holdings业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **2025财年第四季度（截至2025年12月31日）：** - 总产品销售收入：1,280万美元，同比下降56.8%（2024年同期为2,960万美元） - 毛利率：75%，同比提升14个百分点（2024年同期为61%） - GAAP净亏损：1,190万美元，同比扩大13.3%（2024年同期亏损1,050万美元） - 调整后EBITDA：负410万美元，而2024年同期为正340万美元 - 现金及短期投资：6,340万美元，较2025年9月30日的9
03-17 12:14
Assertio Holdings Sees FY2026 Sales $110.000M-$125.000M vs $111.960M Est
Assertio Holdings (NASDAQ:ASRT) sees FY2026 sales of $110.000 million-$125.000 million vs $111.960 million analyst estimate.
03-17 04:13
Assertio Holdings Q4 Adj. EPS $(1.06) Beats $(2.71) Estimate, Sales $13.542M Miss $16.626M Estimate
Assertio Holdings (NASDAQ:ASRT) reported quarterly losses of $(1.06) per share which beat the analyst consensus estimate of $(2.71) by 60.89 percent. This is a 135.56 percent decrease over losses of $(0.45) per share
03-17 04:13
Earnings Scheduled For March 16, 2026
Companies Reporting Before The Bell • CytomX Therapeutics (NASDAQ:CTMX) is expe...
03-16 19:11
美股大行评级 | 潜在涨幅36.7%！LMRI获多家大行首予超配评级； 瑞银下调甲骨文目标价从325美元至280美元
今日重点评级关注：HC Wainwright & Co.：维持Assertio Holdings"买入"评级，目标价从3美元升至35美元；HC Wainwright & Co.：维持万达生物制药"买入"评级，目标价从20美元升至22美元
01-06 17:52
